Literature DB >> 14715780

Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease.

Hsing-Pei Lin1, Yang-Yang Huang, Hsueh-Yin Wu, Jau-Tsuen Kao.   

Abstract

To determine whether DNA detection of high-risk human papillomavirus could represent a reliable screening technique and a useful follow-up method, we investigated the performance of the Hybrid Capture II assay in detecting high-grade cervical lesions. The test positivity at 1.86 pg/ml had a high sensitivity (94.7%) and improved specificity. It was also a suitable follow-up method for detecting the recurrence of cervical intraepithelial disease in patients.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14715780      PMCID： PMC321696          DOI： 10.1128/JCM.42.1.366-368.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Do specific human papillomavirus types cause psoriasis?

Authors:  E M de Villiers; A Ruhland
Journal:  Arch Dermatol       Date:  2001-03

Review 2.  American Cancer Society guideline for the early detection of cervical neoplasia and cancer.

Authors:  Debbie Saslow; Carolyn D Runowicz; Diane Solomon; Anna-Barbara Moscicki; Robert A Smith; Harmon J Eyre; Carmel Cohen
Journal:  CA Cancer J Clin       Date:  2002 Nov-Dec       Impact factor: 508.702

3.  HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.

Authors:  M Schiffman; R Herrero; A Hildesheim; M E Sherman; M Bratti; S Wacholder; M Alfaro; M Hutchinson; J Morales; M D Greenberg; A T Lorincz
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

4.  The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop.

Authors: 
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

5.  Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.

Authors:  E L Franco; L L Villa; J P Sobrinho; J M Prado; M C Rousseau; M Désy; T E Rohan
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

Review 6.  Natural history and epidemiological features of genital HPV infection.

Authors:  A Schneider; L A Koutsky
Journal:  IARC Sci Publ       Date:  1992

7.  Viral load of human papillomavirus and risk of CIN3 or cervical cancer.

Authors:  Attila T Lorincz; Philip E Castle; Mark E Sherman; David R Scott; Andrew G Glass; Sholom Wacholder; Brenda B Rush; Patti E Gravitt; John E Schussler; Mark Schiffman
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

8.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

10.  Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women.

Authors:  C Clavel; M Masure; J P Bory; I Putaud; C Mangeonjean; M Lorenzato; P Nazeyrollas; R Gabriel; C Quereux; P Birembaut
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640
View more
  3 in total

1.  Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

Authors:  Naureen Ehsan Ilahi; Shoaib Naiyar Hashmi; Sobia Anwar; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

2.  Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China.

Authors:  Zhiling Wang; Ying Gu; Hui Wang; Junyu Chen; Yawen Zheng; Baoxia Cui; Xingsheng Yang
Journal:  Virol J       Date:  2020-11-23       Impact factor: 4.099

3.  Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana.

Authors:  A K Awua; S T Sackey; Y D Osei; R H Asmah; E K Wiredu
Journal:  Infect Agent Cancer       Date:  2016-01-26       Impact factor: 2.965
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.